Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia. - Wikidata - awgldk - TriplyDB

Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia.

Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia.

http://www.wikidata.org/entity/Q37188389

about

Circulating biomarkers to monitor cancer progression and treatment miR-155 as a Biomarker in B-Cell Malignancies New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies Clinical significance of microRNAs in chronic and acute human leukemia Tumor-Associated CSF MicroRNAs for the Prediction and Evaluation of CNS Malignancies microRNA: Diagnostic Perspective The circulating transcriptome as a source of non-invasive cancer biomarkers: concepts and controversies of non-coding and coding RNA in body fluids Molecular pathways: microRNAs, cancer cells, and microenvironment MicroRNAs, Major Players in B Cells Homeostasis and Function MicroRNAs, DNA Damage Response, and Cancer Treatment Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia The oncogenic MicroRNA Hsa-miR-155-5p targets the transcription factor ELK3 and links it to the hypoxia response Expression of circulating miRNAs associated with lymphocyte differentiation and activation in CLL-another piece in the puzzle.MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.Plasma Viral miRNAs Indicate a High Prevalence of Occult Viral Infections Prognostic value of miR-21 in various cancers: an updating meta-analysis.New insights into monoclonal B-cell lymphocytosis.A potential regulatory loop between Lin28B:miR‑212 in androgen-independent prostate cancer.Exosomes as divine messengers: are they the Hermes of modern molecular oncology?Role of microRNAs on therapy resistance in Non-Hodgkin's lymphoma.MicroRNA expression differences in human hematopoietic cell lineages enable regulated transgene expression.Characterization of CLL exosomes reveals a distinct microRNA signature and enhanced secretion by activation of BCR signaling MicroRNAome genome: a treasure for cancer diagnosis and therapy.Opposite Prognostic Significance of Cellular and Serum Circulating MicroRNA-150 in Patients with Chronic Lymphocytic Leukemia CLL Exosomes Modulate the Transcriptome and Behaviour of Recipient Stromal Cells and Are Selectively Enriched in miR-202-3p.Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival.Serum Exosome MicroRNA as a Minimally-Invasive Early Biomarker of AML.MicroRNAs as biomarkers in leukemia.Immunomodulatory role of microRNAs transferred by extracellular vesicles.The pivotal role of microRNA-155 in the control of cancer.MicroRNAs and the cancer phenotype: profiling, signatures and clinical implications.The potential of miRNAs as biomarkers for multiple myeloma.Targeting the microRNA-regulating DNA damage/repair pathways in cancer.Shifting paradigms in the treatment of chronic lymphocytic leukemia.Physiological roles of miR-155.Role of microRNA in chronic lymphocytic leukemia onset and progression.MicroRNAs in Myeloid Hematological Malignancies.A Macro View of MicroRNAs: The Discovery of MicroRNAs and Their Role in Hematopoiesis and Hematologic Disease.Current Role of Genetics in Hematologic Malignancies.

P2860

Q26745985-9FD3D9A2-CE71-40EA-AB9E-2A4D0CAE5095 Q26746573-FD99E14B-9BA1-4F60-ACD3-B72585C89697 Q26748881-4ACD4066-2A20-4425-BCBE-E259B0009398 Q26749533-63D39401-5D60-497B-A90D-C098DAE5FDFD Q26774431-8A33CC65-E564-4E4B-B0E1-390023ADEE1D Q26797259-12AB71F0-2235-4113-8603-A2BA1144081F Q26825022-1610E387-DC82-4FD4-AFF9-305D073A3A84 Q27004373-9D0DFD65-010B-4584-B655-A892E37ACCA4 Q27010231-9290C73E-9AF1-4D67-84EB-10CAC16259FA Q28067062-F725DCFF-415A-4135-9527-8636C662584C Q28082120-02C5391A-8D08-4F88-93AA-D0B03570D86E Q28241703-DFA912CF-41F6-4E68-90ED-E3DA4594FB89 Q28545001-683C0ED8-2C63-46A3-98BB-89F418B37CF0 Q33364071-98D4DC9B-FEC1-4820-8CC0-3C9FB1EAA25E Q33607585-4D7A0522-8E17-4909-89C1-20481C30B2D8 Q33817618-FB28CBB0-35EC-4985-A8A1-6CFEAA7ABE29 Q33899211-4EEA9A41-7F1A-4732-9543-B97BECE79E47 Q34256898-9F27E469-8D89-450C-B5CA-41DD4030ABD6 Q34432845-3161BDF6-0465-4D0E-B8F0-9E66BE0FEB46 Q34675263-4F074E60-72A4-4D2A-8C76-17CF68ED5491 Q34769735-8B318F3B-0E78-403F-AC69-9E1D5C890FDF Q35207667-88C5A823-7179-448B-8517-0DA888CF7F10 Q35634885-19C09C58-FC3D-47FE-8E0E-85027A49012C Q35704188-2BA5B024-2D3D-4AE6-9CB2-318B85F7A440 Q35707206-FDA8B0AD-18FA-4FEF-B672-3F09AB1F307C Q35824101-767623CD-47C6-4A62-ABDD-948FF08A7F75 Q35949262-27F37A96-15BF-4F1A-B66A-41C2BBE3F435 Q36294264-F2AF0EFE-60C1-4C8F-93D0-2629F6B13C82 Q37043773-5AD869E3-A107-4048-95AF-07FCED6029DB Q37229687-888D6059-4FC1-41A3-8F0A-6EF01AEF1513 Q38152297-15877048-A5BF-41E2-B68F-53428C3B11F6 Q38174308-CE3B3BEE-89B8-4710-9EB5-3BCEEB7BC05B Q38237446-D6EC9A34-720D-44F4-9CEB-440271870542 Q38246220-C5AD8F21-A72D-4B6C-81F4-1B21374DCD52 Q38357127-B34C35EF-2CCB-4425-A2A5-5C4C1A0F56C4 Q38398527-8A9EF19F-E7F6-4829-BB2F-D6896BBBEED2 Q38426315-5168CB81-2EF2-44BF-AF82-3057A90E4FF0 Q38599595-8C7F1C97-555E-43B7-911B-84DF20A55F33 Q38637596-EFA92BD8-5A85-41FB-9A31-37C06C31960A Q38726143-506F5822-DF8A-442A-9455-24800FD400DE

P2860

Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia.

http://www.wikidata.org/entity/Q37188389

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 02 July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Prognostic value of miR-155 in ...... chronic lymphocytic leukemia.

@en

Prognostic value of miR-155 in ...... chronic lymphocytic leukemia.

@nl

type

label

Prognostic value of miR-155 in ...... chronic lymphocytic leukemia.

@en

Prognostic value of miR-155 in ...... chronic lymphocytic leukemia.

@nl

prefLabel

Prognostic value of miR-155 in ...... chronic lymphocytic leukemia.

@en

Prognostic value of miR-155 in ...... chronic lymphocytic leukemia.

@nl

P1433

Q37188389-1AEEE184-76F1-4FF4-B85D-E5D95FB5031B

P1476

Q37188389-EC5856A0-F34D-4463-973E-EDC54D7D9C8F

P2093

Q37188389-0B4B6F47-C8A2-4D1C-883F-C0B12CA94DE3

Q37188389-21527481-72E5-4A62-9D08-DF0B7957F83C

Q37188389-2DF6023F-08B0-4D49-887E-76EF9051FF27

Q37188389-6BEE5DC1-D0D0-4AA6-92B8-AA138679AF8C

Q37188389-7EF32865-14D9-47AD-BACE-9CE0969C9173

Q37188389-84D7342B-FB38-43B3-A8E0-AE9C26A158DC

Q37188389-8E51C483-BC5F-481A-895E-F27F09310AB9

Q37188389-8EAF2EBC-4C08-4063-85A9-AF67F223F178

Q37188389-905B4D7F-57DF-4699-9F1A-AE6F6610425A

Q37188389-97E7B23C-4CEA-4CC3-8F85-ED821FA869D4

P2860

Q37188389-01E5F45B-3B2E-42FA-A036-E828FEC71236

Q37188389-0CED4F2B-40A7-4EF4-93A2-B2165ECB18FF

Q37188389-216A06AA-AB4C-4EDF-A299-54789239A43D

Q37188389-219FF57D-E8F9-4F5A-AAFC-4143300C6992

Q37188389-2576203C-F1A8-44C0-968F-0F4BE22B3824

Q37188389-34B29B2D-550F-4032-AA7B-191A535D1329

Q37188389-42B54518-A0EB-43EC-94D6-0242F438EA5C

Q37188389-46635100-6E32-46A7-A0DD-BD25309A4841

Q37188389-476BE803-FB3A-4E54-9B71-4AFD34EFFD3D

Q37188389-49A378AA-09B1-4334-9A00-34FC0B89323A

P304

Q37188389-7825CA33-7D66-49E7-9A2D-B49483770AF2

P31

Q37188389-05D7F6C4-131B-4212-9A68-190A80BC394F

P356

Q37188389-27C2356B-F63C-4D8D-A689-DE2A875699A0

P407

Q37188389-041B9E98-03D4-43C9-83D0-E15E8A9A313E

P433

Q37188389-0DFFB197-3D6F-417C-AE50-4AE36AFBCF8B

P478

Q37188389-857987EB-EE51-4B2E-8573-067B40488337

P50

Q37188389-1D945D8B-3346-4660-95BD-DEA81DB92FA0

Q37188389-2F0E3EB9-E5B7-4EAE-9FF8-343E93EEF62B

Q37188389-3D70B25C-AD2B-4EBC-99CF-91AD8D6E74A1

Q37188389-4A16EFCA-1EC4-49D8-8176-92CA7FABC30B

Q37188389-7930E694-19C8-42A0-8D9F-CF17EFD12688

Q37188389-7CB12455-2103-4F66-960E-F70DC15CD372

Q37188389-8DC298D6-2A76-4E8A-9765-47707D8D488F

Q37188389-91981DF4-B2B4-4FB4-94D2-E27EA46E4350

Q37188389-FCABC32D-FB6A-49F3-B700-825B100849B3

P577

Q37188389-B5C5AB7B-23C3-401A-BFCF-F929FC17940C

P5875

Q37188389-4FBFAC8B-3628-4A74-874E-D5299F3A97C6

P698

Q37188389-C61C89BF-6127-41B9-A801-C1F01F32DDEE

P921

Q37188389-1638852F-C077-47E4-B5FE-AA31D493C553

Q37188389-2FD3F735-A3DE-43B6-B825-B1340296689B

Q37188389-E98FE863-817D-4818-BFD9-62DCA0FFD030

P932

Q37188389-374E7FFD-67E5-464C-8D92-EC42C0575884

P356

BLOOD-2013-01-478222

P1433

P1476

Prognostic value of miR-155 in ...... chronic lymphocytic leukemia.

@en

P2093

Asish K Ghosh

http://www.w3.org/2001/XMLSchema#string

James M Reuben

http://www.w3.org/2001/XMLSchema#string

Jianhua Hu

http://www.w3.org/2001/XMLSchema#string

John T Manning

http://www.w3.org/2001/XMLSchema#string

Kari G Rabe

http://www.w3.org/2001/XMLSchema#string

Laura Z Rassenti

http://www.w3.org/2001/XMLSchema#string

Lianchun Xiao

http://www.w3.org/2001/XMLSchema#string

M James You

http://www.w3.org/2001/XMLSchema#string

Mariko Ikuo

http://www.w3.org/2001/XMLSchema#string

Masayoshi Shimizu

http://www.w3.org/2001/XMLSchema#string

P2860

MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

MicroRNAs: genomics, biogenesis, mechanism, and function

microRNAs: tiny regulators with great potential

The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments

The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia

A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia

Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice

Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression.

Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia

P304

1891-1899

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2013-01-478222

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

122

http://www.w3.org/2001/XMLSchema#string

P50

Alessandra Ferrajoli

William G Wierda

George A. Calin

Michael J. Keating

P577

2013-07-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

244992470

http://www.w3.org/2001/XMLSchema#string

P698

23821659

http://www.w3.org/2001/XMLSchema#string

P921

P932

3779381

http://www.w3.org/2001/XMLSchema#string